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Insight into Binding of Calyculin A to Protein
Phosphatase 1: Isolation of Hemicalyculin A
and Chemical Transformation of Calyculin A
microcystin LR are involved [8]. Although a number of
molecular modeling studies have been done for com-
plexes between PP1 and other inhibitors, there is no
clear evidence for their modes of binding to the enzyme
[9–14]. A crystal structure of the complex between oka-
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The University of Tokyo daic acid and PP1c has recently been reported [15].
Calyculin A (4) was isolated from the marine spongeBunkyo-ku, Tokyo 113-8657
Japan Discodermia calyx as an antitumor agent, and it was
later found to inhibit PP1 and PP2A with IC50 values of2 Department of Physiology
Asahikawa Medical College 1.4 and 2.6 nM, respectively [16]. It is also a potent
tumor promoter; this activity is ascribed to inhibition ofAsahikawa, Hokkaido 078-8510
Japan the protein phosphatases [17]. Seventeen natural caly-
culin derivatives, including clavosines, 21-glycosylated
derivatives, have been isolated from several marine
sponges [18–24]. Initially, we reported that dephospho-Summary
nocalyculin A was as potent as calyculin A in inhibition
of PP1 and PP2A [23]. This is puzzling because theCalyculin A isolated from the marine sponge Disco-
acidic group was considered to be essential for thedermia calyx is a potent inhibitor of protein phospha-
inhibition of the enzymes, which was indicated by mo-tases 1 and 2A. We attempted to elucidate its mode
lecular modeling studies of complexes between PP1 andof binding to the enzymes by examining the activity of
calyculins based on the PP1c/microcystin LR complexnatural and chemically transformed derivatives. Ten
model [9–14]. In addition to this point, other structuralnatural derivatives including a new compound, hemi-
requirements for the inhibition of PP1 remained unclear.calyculin A, were provided. The structure of hemicaly-
To clarify these important issues, we attempted natural-culin A, which comprises the southern hemisphere of
products chemical approaches; isolation of new conge-calyculin A, was firmly established by chemical meth-
ners, and preparation of fragments of calyculin A. Weods. Six compounds were prepared by selective modi-
also purified natural calyculin derivatives very carefullyfications of functional groups in calyculin A. The en-
before evaluating their biological activities.zyme inhibitory activity of these compounds indicated
In this paper we describe the isolation and structurethat 17-phosphate, 13-hydroxyl, and the hydrophobic
of hemicalyculin A, a truncated calyculin A, from D. calyx,tetraene moieties were all necessary for binding to the
preparation of derivatives of calyculin A, and PP1 andenzymes. The derivatives lacking the peptide portion
PP2A inhibition and cytotoxicity of these derivatives andwere less cytotoxic even when they possessed full
of natural calyculins previously obtained. We proposeenzyme inhibitory activity.
that 17-phosphate, 13-hydoxyl, and tetraene moieties
are essential for inhibition of PP1 and PP2A.
Introduction
Reversible protein serine/threonine phosphorylation Results
regulates numerous cellular functions, including muscle
contraction, neurotransmission, cell proliferation, carci- Isolation and Structure Elucidation of a New
nogenesis, and apoptosis [1–3]. A large number of pro- Compound, Hemicalyculin A (5)
tein kinases have been well investigated for several de- In the course of bioassay-guided fractionation of the
cades [4–6], but it has not been until recently that our extract of D. calyx, we have discovered a prominent new
understanding on protein phosphatases, namely PP1, derivative, hemicalyculin A (5). The organic fraction of
PP2A, PP2B, and PP2C, has been considerably deep- the crude extract was chromatographed over silica gel.
ened by the discovery of natural product inhibitors [7]. Fractions that inhibited PP1 were further separated by
PP1 and PP2A are strongly inhibited by a diverse array ODS flash chromatography followed by HPLC to afford
of natural products, e.g., polyether polyketides such as hemicalyculin A (5, 1.2  104% wet weight), which
okadaic acid (1) and tautomycin (2), nonribosomal pep- showed UV absorption at 340 nm but no absorption at
tides represented by microcystin LR (3), and polyketide/ 230 nm, indicating the lack of the oxazole unit.
nonribosomal peptides such as calyculin A (4) (Figure 1). Hemicalyculin A (5) had a molecular formula of
Interestingly, these compounds contain acidic moieties C36H55N2O10P, as established by HRFABMS and NMR
that are in fact essential for their inhibitory activity [7]. spectral data. The 1H NMR spectrum exhibited diag-
The crystal structure of the complex of PP1c and micro- nostic signals for calyculins: an O-methyl, five singlet
cystin LR clearly show the ionic, hydrophobic, and cova- C-methyls, and three doublet methyls, while the signals
lent interactions between the inhibitor and the enzyme, for an oxazole and N-methyls were missing. The 13C
in which the Masp/Glu, Adda, and Mdha residues of NMR spectrum revealed the presence of a phosphate
on C17 because pertinent signals (C16, C17, and H17)
were doubled because of coupling to a phosphorus3 Correspondence: anobu@mail.ecc.u-tokyo.ac.jp
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Figure 1. Structures of Protein Phosphatase Inhibitors
atom. Interpretation of the COSY and HMQC spectra lysis of which proceeded smoothly to afford 9. Hemicaly-
culin A (5) was similarly treated to give 9, which wasdisclosed that the structural unit C1 through C26 was
identical to that of calyculin A (4). HMBC crosspeaks spectroscopically indistinguishable from its counterpart
derived from 4. Therefore, all the stereogenic centers inamong H25, H26, and a carbon at 118.8 ppm were remi-
niscent of a nitrile group attached to C26. NOESY corre- hemicalyculin A (5) were shown to have the same abso-
lute stereochemistry as the corresponding centers inlations implied that the geometry of the tetraene unit
was identical to that in 4. calyculin A (4).
After completion of the above chemical transformations,1H, 1H-coupling constants and NOESY data showed
that the relative stereochemistry of the portion from C1 we noticed that oxidative cleavage of an oxazole affords
a nitrile [25]. This reaction proceeds through an epidioxideto C8 and from C15 to C25 in 5 was the same as in 4.
However, the stereochemistry of the C9–C13 portion intermediate, which then undergoes rearrangement to
form a cyanide and an anhydride. In a similar fashion,could not be firmly determined on the basis of NMR
data. Accordingly, we attempted to obtain the common calyculin A (4) may be converted to hemicalyculin A (5).
In fact, calyculin A furnished 5 in 5% yield upon treat-core portion from each compound that contained all
chiral centers by oxidative cleavage of the olefinic bonds ment with singlet oxygen. It should be noted that the
reaction barely proceeds in the absence of methylenebetween C8 and C9 and between C25 and C26 (Figure
2). Oxidation of 4 with RuO4, OsO4/NaIO4, or O3 afforded blue. Therefore, we believe that hemicalyculin A (5) is not
an artifact formed from 4 during isolation work.inseparable mixtures. In order to circumvent the prob-
lem, we sought to fully protect calyculin A before ozono-
lysis. The 11,13-diol was selectively protected as an Chemical Transformation of Calyculin A
In order to obtain further information of the structure-acetonide to afford 6, whose 34,35-diol was then
cleaved with NaIO4, followed by reduction with NaBH4 activity relationships for the calyculins, we carried out
several chemical transformations of calyculin A (4).to furnish 7. The phosphate group in 7 was protected
by p-bromobenzylation, yielding compound 8, ozono- After several trials to protect the diol groups in caly-
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Figure 2. Preparation of 9 from Calyculin A (4) and Hemicalyculin A (5)
culin A (4), we selected the acetonide. Upon isopropyli- these different reactivities of the two acetonides allowed
us to prepare 11,13-O-isopropylidenecalyculin A (6) anddenation, calyculin A preferentially afforded 11,13-O-
isopropylidene-calyculin A (6); the second acetonide 34,35-O-isopropylidenecalyculin A (11).
Treatment of calyculin A with Ac2O/pyridine providedgroup at the 34,35-diol was introduced only at elevated
temperatures. It should be noted that the 11,13-aceto- a complex mixture. FABMS and HPLC analyses of the
reaction mixture indicated that calyculin A peracetatenide was removable with 80% AcOH, whereas it was
not possible to deprotect the 34,35-acetonide without was formed. However, undesired reactions took place
during work-up, as revealed by HPLC. NMR and MSaffecting other functionalities. A similar phenomenon
was observed in the removal of the 34,35-acetonide analyses of the products indicated that the complexity
arose from the hydrolysis of the acetates at C34 andfrom the fully protected calyculin A [26]. Fortunately,
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Table 1. Protein Phosphatase Inhibitory Activity of Calyculin Derivatives
(continued)
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C35. The selectivity appeared to be due to the basicity MeOH as the mobile phase was further separable by
HPLC with aqueous MeCN. The dephosphonocalyculinof the neighboring dimethylamino group. When the acet-
ylation product was kept in MeOH for 10 days, metha- A-rich fraction obtained during isolation of hemicalyculin
A (5), which gave a single peak in the HPLC with aqueousnolysis of the 34- and 35-acetates proceeded, and the
product was converged to calyculin A 11,13,21-triace- MeOH and had significant enzyme-inhibitory activity,
was further purified by HPLC with aqueous MeCN, whichtate (12).
To evaluate the contribution of the 21-hydroxyl group, afforded a preparation of dephosphonocalyculin A (17)
with essentially no enzyme-inhibitory activity. It is likelywe selectively acetylated this group. For that purpose,
11,13-O-isoprolylidene-calyculin A (6) was peracetyl- that the potent activity of the intermediate HPLC fraction
was due to the presence of a highly active contami-ated, and the product was kept in MeOH for 10 days to
remove the acetyl groups at C34 and C35. Removal nant(s). However, at this moment we have no idea as
to the character of the active species. We now concludeof the 11,13-acetonide with aqueous AcOH provided
calyculin A 21-acetate (13). that the phosphate group in calyculin A is absolutely
essential for the inhibition of PP1 and PP2A.Because X-ray crystallography revealed that the 36-
dimethylamino group significantly contributed to stabili-
zation of the pseudocyclic conformation of calyculin A The 1-Cyano Group
(4) by forming a salt bridge with the 17-phosphate group Calyculinamide A (18) is as potent as calyculin A (4); the
[18], the effect of this group on biological activities of two compounds differ only in the terminal structure. The
calyculins is interesting. Although selective modification former has an amide terminus, whereas the latter has a
of this group was not possible, it was removed by cleav- cyano group. It is possible that the nitrile and amide
age of the bond between C34 and C35. However, upon groups in both compounds may interact with the enzyme
NaIO4 oxidation of the unprotected calyculin A, the through the formation of one or more hydrogen bonds.
cleavage of the relevant bond took place with concomi- A significantly lower activity of calyculin B (19) [19] may
tant formation of an iodinated tetrahydrofuran ring anal- be ascribable to either a loss of the hydrogen bonding
ogous to the one in calyculin J (14) [19]. In order to interaction or a repulsion caused by the displaced cyano
prevent this side reaction, 11,13-O-isopropylidenecaly- group.
culin A (6) was oxidized with NaIO4 followed by reduction
with NaBH4 and deprotection of the acetonide to afford The Dimethylamino Group at C36C1/C34-calyculin A (15).
Dimethylamino groups are found in many potent bioac-Although proposed by modeling studies, the impor-
tive compounds and are considered to play an importanttance of the hydrophobic tail of calyculin A has not been
role in exerting their activities [27, 28]. In our earlierdemonstrated experimentally. Therefore, we prepared
study, des-N-methyl-calyculin A (20) was significantlyC9/C25-calyculin (16) that lacked the tetraene unit and
less active than calyculin A (4) [22]. Reexamination withthe portion from C26 to C45. Removal of the acetonide
larger amounts of des-N-methyl-calyculin A (20) resultedin fragment 9 with 80% AcOH followed by hydogenolysis
in comparable activity to that of calyculin A, suggestingafforded compound 16.
that the basicity of the dimethylamino group is less im-
portant in binding to the enzymes, which was also sup-
Protein Phosphatase Inhibitory Activities ported by potent activity observed in C1/C34-calyculin
The enzyme inhibitory activities of ten natural [18–20, A (15).
22, 23] and six chemically transformed derivatives are
shown in Table 1. Eight compounds exhibited activity Hydroxyl Groups
as potent as that of calyculin A; four of them were essen- Among a total of five hydroxyl groups in calyculin A, the
tially inactive, and the remaining four derivatives had one on C21 is clearly not involved in binding to the
partly lost activity. enzyme, which was indicated by potent activity of cla-
vosine A (21) (Figure 1), a glycosylated derivative of
21-epi-calyculinamide C [24]. This was supported byDiscussion
retained activity of calyculin A 21-acetate (13). 34,35-O-
isopropylidenecalyculin A (11) was as active as calyculinThe Phosphate Group on C17
All potent natural phosphatase inhibitors so far obtained A and thus demonstrated the irrelevance of the hydroxyl
groups on C34 and C35 in enzyme inhibition. This iscontain one or two acidic groups, which are the carbox-
ylic acid in microcystin LR (3), okadaic acid (1), and consistent with the potent activity of C1/C34-calyculin
A (15), which lacks the 35-hydroxyl group.tautomycin (2) and the phosphate group in calyculin A
(4) [7]. It is widely accepted that these acidic groups In stark contrast to the above-mentioned derivatives,
11,13-O-isopropylidenecalyculin A (6) did not inhibit themimic the phosphorylated serine or threonine residues
in the substrate. enzyme even at 10 g/ml. X-ray crystallography and
NMR analysis of calyculin A [17] showed that the C1–C15In our earlier studies, dephosphonocalyculin A (17)
inhibited both PP1 and PP2A as strongly as calyculin side chain is not in the fully extended conformation due
to the repulsion of the methyl groups on C10 and C12;A, which led to the hypothesis that the structural part
of calyculin A, other than the phosphate group, would the chain bends at the bond between C10 and C11. It
would be possible that incorporation of a rigid dioxaneparticipate in binding to the enzymes [23]. During purifi-
cation of hemicalyculin A (5), we experienced that a ring might prevent the side chain from adopting the
specific conformation required for activity. In order tofraction that gave one peak in ODS-HPLC with aqueous
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PP1 and PP2A, allowing us to confirm the indispensabil-Table 2. Cytotoxicity against P388
ity of the hydrophobic tail in calyculins.
Calyculin A (4) 0.170
Hemicalyculin A (5) 450
C1/C34-calyculin A (15) 40 Structural Units Interacting with Enzymes
Dephosphonocalyculin A (17) 5000 Five research groups have reported molecular modeling
11,13-O-isopropylidenecalyculin A (6) 2000
studies of the binding of calyculin A to PP1 [9–14]. Al-
IC50 is in ng/ml though all workers used the crystal structure of micro-
cystin LR bound PP1c as a template, they proposed
two different gross shapes for the “bound” calyculin A.
A recent study on the solution structure of calyculin Adisprove the idea, we examined calyculin A 11,13,21-
has shown conformational aspects of the molecule; intriacetate (12). The triacetate was also inactive, substan-
CDCl3 calyculin A adopts a pseudocyclic conformation,tiating the importance of the hydroxyl groups on C11
as observed in the crystal structure, whereas in CD3ODand C13. Calyculin J (14), which lacks the 11-hydroxyl
some of polar groups are solvent exposed [29]. There-group [22], was as active as calyculin B (19). If the two
fore, it is possible that the conformation of calyculincompounds’ diminished activities compared with that
A changes depending on the local environment of theof calyculin A are due to the perturbation caused by the
binding site of PP1.disorientation of the hydrophobic tail with respect to the
All modeling studies suggested that the tetraene por-spiroketal [11], the contribution of the 11-hydroxyl group
tion of calyculin A plays the same role as the Adda sideto the activity appears to be minimal.
chain in microcystin LR. However, the importance of the
phosphate group was not emphasized by some groups
Oxazole Ring and the C30–C32 Linker [10, 14] because of a previous report on the potent
The oxazole ring placed near the center of the molecule activity of dephosphonocalyculin A. Although not in-
functions not only to force the linear molecule to bend volved in binding to microcystin LR, the acidic groove
but also to form a salt bridge with the phosphate; it of PP1 was suggested to play an important part in bind-
thereby serves to determine the overall shape of caly- ing to calyculin A through interactions concerning the
culin A (4) in the solid [18] and liquid [29] states. In spite 36-dimethylamino group [7, 11]. When the phosphate
of its architectural importance, the oxazole ring was function in calyculin A binds to the catalytic site of the
shown not to be required for the activity since hemicaly- enzyme and if calyculin A adopts an extended conforma-
culin A (5) retained the almost identical activity as caly- tion, the 36-dimethylamino group is suitably placed in
culin A. The potent activity of hemicalyculin A (5) clearly the vicinity of the acidic groove of PP1 to effect ionic
demonstrated that the densely functionalized -amino interaction. However, this proposal is inconsistent with
acid and the C30–C32 linker were also unnecessary for the potent activity of calyculin A toward the PP1 mutants
enzyme inhibition. whose acidic groove residues are replaced by basic or
neutral residues [31]. In any case, the molecular model-
ing studies of calyculin A did not converge either inTetraene Terminus
the bound conformation of calyculin A or in importantAll potent natural inhibitors, such as okadaic acid (1)
functional groups. This is partly because of the lack ofand microcystin LR (3), have a bulky hydrophobic tail,
precise SAR data for the calyculins.which was shown to be important for enzyme inhibition
If we presume that a structural unit whose modifica-[7]. The crystal structure of a PP1c/microcystin-LR com-
tion abolishes the inhibitory activity is involved in bindingplex showed that the Adda [(2S,3S,8S,9S)-3-amino-9-
to the enzyme, three such units could be pointed outmethoxy-2,6,8-trimethyl-10-phenyl-4E,6E-decadienoic
for calyculin A: 17-phosphate, 13-hydroxyl, and the te-acid] side chain of microcystin-LR (3) is accommodated
traene moieties. These functional groups are all locatedin the hydrophobic groove [8]. The SAR studies of micro-
in the polyketide portion. When the three groups interactcystins revealed that the congeners with the 6Z-Adda
with the enzyme at the same time, the central spiroketalresidue were less active [30], implying the importance
portion must be placed apart from the peptide portionof the shape of the hydrophobic tail for accommodating
by the breakdown of the intramolecular salt bridges.the hydrophobic groove of the enzyme [8]. In contrast
Additionally, the interaction of calyculin A (4) with thewith this idea, calyculins A (4), B (19), E (22), and F
acidic groove is shown not to be important because(23), which are geometrical isomers of olefins in the
hemicalyculin A (5) and C1/C34-calyclulin A (15), bothhydrophobic tail, i.e., the tetraene portion, showed simi-
of which lack the dimethylamino group, are as potentlar IC50 values against PP1 and PP2A in our earlier report inhibitors as calyculin A (4).[20]. It is now conceivable that we measured the activity
of a mixture of four compounds in each case because
of facile photoisomerization of the double bonds [20]. Cytotoxicity
Finally, we compared the enzyme inhibitory and cyto-We prepared calyculins by avoiding light as much as
possible and determined their enzyme-inhibitory activity toxic activities of selected calyculin derivatives (Table 2).
Three compounds with comparable enzyme inhibitoryin the dark. Consequently, calyculins B, E, and F were
shown to be significantly less active than calyculin A activity (calyculin A [4], hemicalyculin A [5], and C1/C34-
calyculin A [15]) and two inactive derivatives (dephos-(Table 1). In order to examine the role of the hydrophobic
tail as a whole in calyculin A (4), we examined the activity phonocalyculin A [17] and 11,13-O-isopropylidenecaly-
culin A [6]) were chosen. The cytotoxicity of the potentof the C9/C25-calyculin (16). It was inactive against both
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Table 3. 1H and 13C NMR data for 5 (in CD3OD, 300 K)
Carbon 1H, ppm Carbon 1H, ppm
Number 13C, ppm (mult,J(Hz)) Number 13C, ppm (mult,J(Hz))
1 118.1 --- 20a 30.6 1.60 (dd,14.4,2.7)
2 96.2 5.26 (s) 20b --- 1.86 (dd,14.4,3.9)
3 158.8 --- 21 71.9 3.97 (q,3.0)
4 129.1 6.77 (d,15) 22 38.9 1.61 (m)
5 135.5 7.15 (dd,15,11) 23 67.4 4.42 (dt,9.3,2.8)
6 125.3 6.38 (d,11) 24a 37.9 2.20 (ddd,3.5,9.2,13.7)
7 145.7 --- 24b --- 2.46 (dddd,1.8,5.3,10.0,15.0)
8 136.9 --- 25 156.0 7.06 (ddd,16.0,9.2,5.4)
9 132.6 6.02 (d,10) 26 101.9 5.66 (d,16.0)
10 37.4 2.80 (ddq,6.9,2.3) 27 118.8 ---
11 79.0 3.44 (dd,9.6,2.7) 42 10.5 0.88 (d,7.3)
12 44.1 1.67 (ddq,5.3,7.0,9.0) 43 23.0 0.98 (s)
13 71.8 4.12 (dd,5.7,10.4) 44 18.1 1.20 (s)
14a 35.2 1.48 (dd,9.8,13.6) 45 60.8 3.63 (s)
14b --- 1.80 (dd,11.2,14.6) 46 11.9 0.79 (d,6.0)
15 80.3 3.81 (dt,9.6,0.7) 47 18.5 1.06 (d,6.9)
16 85.9 4.14 (dd,9.6,5.7) 48 14.2 1.89 (s)
17 85.2 4.16 (dd,10.0,4.6) 49 14.9 2.05 (s)
18 51.7 --- 50 19.2 2.10 (s)
19 109.8 ---
The NMR data were recorded at 600 MHz for 1H NMR and at 150 MHz for 13C NMR. The chemical shifts are recorded as  ppm.
enzyme inhibitors were in the order of calyculin A (4) ing model of microcystin LR to PP1c that was obtained
by X-ray crystallography of the microcystin LR/PP1cC1/C34-calyculin A (15) hemicalyculin A (5). Hemicaly-
culin A (5) lacked two of the basic groups, the dimethyl- complex. It is also demonstrated that the cytotoxic
activity of the calyculins is ascribed to their inhibitionamino and oxazole groups, whereas C1/C34-calyculin
A lacked only the dimethylamino group. Therefore, the of PP1 and PP2A. Our new finding will contribute not
only to the design of inhibitors of enzymes but also tocytotoxicity of the potent enzyme inhibitory compounds
was in the reverse order of their acidity, demonstrating the development of anticancer agents.
that both dimethylamino and oxazole groups served to
cancel the negative charges of the phosphate group by Experimental Procedures
forming salt bridges as revealed by the crystal structure
Ultraviolet spectra were measured on a Hitachi 330 spectrophotom-and that they facilitated membrane permeation. The
eter. Optical rotations were determined with a JASCO DIP-1000morphological change of 3Y1 fibroblast cells occurred
polarimeter. FAB mass spectra were measured with a JEOL SX-102in 7 min when the cells were exposed to 100 nM of
mass spectrometer. 1H and 13C NMR spectra were recorded oncalyculin A (4), whereas no change was observed for 3
a JEOL JNM-A600 NMR spectrometer. The sponge D. calyx was
hr in those treated with 1M of hemicalyculin A (5). 6 and collected by hand with SCUBA at depths of 15–20 min off the Izu
17, two apparently membrane-permeable compounds Peninsula and Sikine-jima island. Specimens were immediately fro-
zen and kept frozen at 20C until processed. A protein phospha-with no enzyme-inhibitory activities, exhibited essen-
tase inhibitory assay was carried out as described in the literaturetially no cytotoxic activity.
[33]. The activity was expressed by the IC50 value, which is affected
by the enzyme concentration in the assay solution. Therefore, the
Significance difference of the activities of compounds with IC50 values around 1
nM was not evaluated precisely.
Reversible serine/threonine phosphorylation regu-
lates countless cellular processes. The recent discov-
Isolation of Hemicalyculin A (5)
ery of natural product inhibitors, including okadaic The sponge D. calyx was collected at a depth of 5 m off Sikine-jima
acid, calyculin A, and microcystin LR, has shed light island, 100 km south of Tokyo. Specimens were immediately frozen
and kept frozen at 20C until processed. After epibionts wereon the functions of protein phosphatases, e.g., PP1
removed, the frozen sponge (10 kg) was homogenized and extractedand PP2A. Inhibitors of these enzymes are believed to
with ethanol (2  6 liters) and methanol (2  6 liters). The combinedbe potential therapeutic agents, particularly antitumor
extracts were concentrated and partitioned between CH2Cl2 andagents [32]. To obtain insight into the mode of interac-
H2O. The organic phase (29 g) was subjected to silica gel flashtion between calyculin A and the enzymes, we have chromatography with CHCl3/MeOH solvent pairs. Enzyme-inhibitory
examined the PP1 and PP2A inhibitory activity of a fractions containing the CHCl3/MeOH (98:2), CHCl3/MeOH (95:5),
and CHCl3/MeOH (9:1) fractions were subjected to ODS flash chro-new calyculin derivative, hemicalyculin A (5), and
matography with aqueous methanol. All 30 fractions were monitoredchemically transformed calyculin derivatives as well
by the diode-array-detected HPLC with ODS column. The fractionsas 10 natural calyculins, which provided significant
containing hemicalyculin A were further purified by ODS HPLC withstructure-activity relationships for the calyculins and
68% MeOH containing 50 mM AcONH4 and then with 45% MeCNthereby suggested that the 17-phosphate, 13-hydroxyl, containing 50 mM AcONH4 to yield 5 (12 mg).
and tetraene moieties are involved in binding to PP1 Hemicalyculin A (5) colorless solid: []20D 107 (c 0.5, MeOH);
UV 	max (MeOH), 237 nm (
 3700), 340 nm (
 19000); HRFABMS [m/zand PP2A. This new finding is consistent with the bind-
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705.3513 (M-H)-, C36H55N2O10P ( 0.3 mmu)]; for 1H and 13C NMR (1H, m, H20a), 1.61 (1H, m, H12), 1.65 (1H, m, H22), 1.85 (1H, m,
H31a), 1.86 (1H, m, H20b), 1.89 (1H, m, 14b), 1.89 (3H, s, H48), 2.04data, see Table 3.
(3H, s, H49), 2.07 (1H, m, H31b), 2.09 (1H, m, H24a), 2.10 (3H, s,
H50), 2.12 (1H, m, H24a), 2.47 (1H, m, H24b), 2.55 (6H, s, H39,40),Preparation of 9 from Calyculin A (4)
2.79 (1H, m, H10), 3.09 (1H, m, H30), 3.28 (3H, s, H38), 3.36 (1H, m,To a solution of calyculin A (4, 10 mg) in CH2Cl2 (500 l) was added
H36), 3.40 (1H, m, H37a), 3.47 (1H, m, H11), 3.58 (3H, s, H45), 3.632,2-dimethoxypropane (300 l) and pyridinium p-toluenesulfonate
(1H, m, H37b), 3.85 (1H, m, H21), 3.90 (1H, m, H13), 3.91 (1H, m,(PPTS, 12 mg), and the mixture was stirred at 40C for 20 hr, followed
H15), 4.12 (1H, dd, H16), 4.40 (1H, m, H17), 4.41 (1H, m, H23), 4.66by the addition of three drops of triethylamine and evaporation. The
(1H, m, H35), 5.27 (1H, s, H2), 6.02 (1H, d, H9), 6.25 (1H, d, H26),residue was purified by ODS HPLC with 75% MeOH containing 50
6.38 (1H, d, H4), 6.61 (1H, m, H25), 6.68 (1H, d, H6), 7.15 (1H, dd,mM AcONH4 to furnish 11,13-O-isopropylidene-calyculin A (6). To a
H5), 7.90 (1H, s, H28).; 13C NMR (MeOHd4 at 300 K)  10.8 (C42),solution of 6 in 80% MeOH (1 ml) was added NaIO4 (5 mg), and the
12.2 (C46), 12.5 (C48), 14.3 (C48), 15.0 (C49), 18.1 (C44), 18.5 (C47),mixture was stirred at room temperature for 2 hr. Then the reaction
18.5 (C50), 23.1 (C43), 24.5 (acetonide-Me), 27.0 (acetonide-Me),mixture was treated with NaBH4 (5 mg) and stirred at room tempera-
31.1 (C20), 32.9 (C30), 35.2 (C14), 37.2 (C10), 37.2 (C24), 38.0 (C32),ture for 2 hr. The reaction was quenched by addition of AcOH (50
38.8 (C22), 41.9 (C39,40), 44.3 (C12), 59.7 (C38), 60.3 (C45), 64.0l), and the reaction mixture was diluted with H2O followed by extrac-
(C36), 68.2 (C23), 72.4 (C21), 75.8 (C34), 76.9 (C35), 79.4 (C11), 80.8tion with EtOAc to afford 7. The material was dissolved in DMF (500
(C15), 84.0 (C17), 85.9 (C16), 95.2 (C2), 132.9 (C9), 120.4 (C26), 125.5l) and treated with KF (5 mg) and p-bromobenzylbromide (30 mg)
(C4), 129.3 (C6), 135.4 (C5), 136.3 (C28).at 50C overnight. The reaction mixture was diluted with H2O and
desalted through an ODS short column. The MeOH eluate from the
column was purified by ODS HPLC with 88% MeCN containing 50 Preparation of Calyculin A 11,13,21-Triacetate (12)
mM AcONH4 to afford 8. Compound 8 was ozonized for 5 min Calyculin A (4, 10 mg) was dissolved in acetic anhydride/pyridine
at 78C in CH2Cl2, and the reaction mixture was reduced with (1:1), and the mixture was stirred at room temperature overnight.
NaBH4 (8 mg) and MeOH (800 l) and stirred at room temperature The reaction mixture was evaporated and then dissolved in MeOH.
for 5 hr. The reaction was stopped by the addition of AcOH, and After standing for a week, the MeOH solution was purified by ODS
the mixture was evaporated, then purified by ODS HPLC with 90% HPLC with 62% MeCN containing 50 mM AcONH4 to afford calyculin
MeOH containing 50 mM AcONH4 to furnish 9 (2.8 mg; []20D 33 A triacetate (12, 5.2 mg).
[c 0.1, MeOH]). Calyculin A 11,13,21-triacetate (12): HRFABMS (positive; NBA)
m/z 1135.5826 (C56H88O18N4P,  0.5 mmu); 1H NMR (MeOH-d4 at
Preparation of 9 from Hemicalyculin A (5) 300 K)  0.94 (3H, d, H46), 0.96 (3H, d, H47), 0.97 (3H, d, H42), 0.97
To a solution of hemicalyculin A (5, 2 mg) in CH2Cl2 (300 l) were (3H, s, H43), 1.29 (3H, s, H44), 1.35 (3H, d, H41), 1.40 (1H, m, H14a),
added 2,2-dimethoxypropane (300 l) and pyridinium p-toluenesul- 1.69 (1H, m, H22), 1.83 (1H, m, H31a), 1.84 (1H, m, H20b), 1.88 (3H,
fonate (5 mg), and the mixture was stirred at 40C for 20 hr. The s, H48), 1.96 (3H, s, Ac), 1.98 (3H, s, H49), 2.04 (3H, s, Ac), 2.06 (1H,
reaction solution was basified by the addition of three drops of m, H24a), 2.06 (3H, s, Ac), 2.08 (1H, m, H12), 2.08 (1H, m, H31b),
triethylamine and evaporated. The residue was purified by ODS 2.09 (3H, s, H50), 2.45 (1H, m, H14b), 2.45 (1H, m, H24b), 2.92 (6H,
HPLC with 82% MeOH containing 50 mM AcONH4 to furnish 11,13- s, H39, 40), 2.98 (1H, m, H10), 3.08 (1H, m, H32a), 3.23 (1H, m, H30),
O-isopropylidene-hemicalyculin A. The product was dissolved in 3.38 (1H, m, H15), 3.42 (3H, s, H38), 3.47 (3H, s, H45), 3.68 (1H, m,
DMF (500 l) and treated with KF (3 mg) and p-bromobenzylbromide H32b), 3.84 (1H, m, H37a), 3.85 (1H, m, H36), 3.87 (1H, m, H35), 3.95
(30 mg) at 50C overnight. The reaction mixture was diluted with (1H, m, H37b), 3.95 (1H, m, H16), 4.38 (1H, m, H23), 4.38 (1H, m,
H2O and desalted on an ODS short column. The MeOH eluate from H17), 4.44 (1H, d, H34), 4.83 (1H, m, H11), 4.88 (1H, m, H21), 5.26
the column was purified by ODS HPLC with 95% MeOH containing (1H, m, H13), 5.30 (1H, s, H2), 5.78 (1H, d, H9), 6.23 (1H, d, H26),
50 mM AcONH4 to afford 10. Compound 10 was ozonized for 5 min 6.39 (1H, d, H6), 6.78 (1H, d, H4), 6.88 (1H, ddd, H25), 7.13 (1H, dd,
at 78C in CH2Cl2. The product was treated with NaBH4 (6 mg) and H5), 7.70 (1H, s, H28).; 13C NMR (MeOH-d4 at 300 K)  10.8 (C42),
MeOH (600 l) at room temperature for 5 hr. The reaction was 11.8 (C46), 13.8 (C48), 14.2 (C49), 16.2 (C41), 17.3 (C47), 18.2 (C44),
stopped by the addition of AcOH, and the mixture was evaporated, 18.7 (C50), 19.0 (Ac), 21.7 (Ac), 22.0 (Ac), 22.1 (Ac), 22.4 (C43), 27.8
then purified by ODS HPLC with 90% MeOH containing 50 mM (C20), 29.9 (C14), 30.3 (C30), 35.1 (C10), 35.3 (C22), 35.3 (C31), 35.3
AcONH4 to furnish 9 (1.4 mg; []20D 31 [c 0.1, MeOH]). (C24), 35.3 (C32), 42.2 (C39,40), 59.0 (C38), 61.0 (C45), 66.4 (C36),
66.7 (C37), 68.1 (C23), 72.5 (C34), 72.5 (C13), 74.2 (C35), 75.0 (C21),
79.8 (C11), 79.8 (C15), 84.1 (C17), 87.5 (C16), 95.7 (C2), 119.2 (C26),Photo-Oxidation of Calyculin A
126.3 (C6), 130.0 (C4), 132.1 (C9), 134.0 (C5), 135.2 (C25), 136.2Calyculin A (4, 10 mg) was irradiated in CH2Cl2 (500 l) under two
(C28).500 W flood lamps at 78C for 1 hr with bubbling O2 gas in the
presence of methylene blue as a sensitizer. The reaction mixture
was evaporated. The residue was dissolved in MeOH and passed Preparation of Calyculin A 21-Acetate (13)
through a short column packed with 2 ml of Dowex 50 W (Na form). 11,13-O-isopropylidene-calyculin A (6, 10 mg) was dissolved in ace-
The MeOH eluent was further purified by ODS HPLC with 68% MeOH tic anhydride/pyridine (1:1) and stirred at room temperature over-
containing 50 mM AcONH4 and then with 45% MeCN containing 50 night. The reaction mixture was evaporated and then dissolved in
mM AcONH4 to yield hemicalyculin A (5, 0.5 mg). MeOH. After standing for 10 days, the MeOH solution was evapo-
rated and dissolved in 80% AcOH (500 l), and this solution was
stirred at 50C overnight. The product was purified by ODS HPLCPreparation of 34,35-O-Isopropylidene-Calyculin A (11)
To a solution of calyculin A (4, 2 mg) in CH2Cl2 (300 l) were added with 90% MeOH containing 50 mM AcONH4 to afford calyculin A
C21-acetate (13, 4.4 mg).2,2-dimethoxypropane (300 l) and pyridinium p-toluenesulfonate
(5 mg), and the mixture was stirred at 60C for 24 hr. The reaction Calyculin A 21-acetate (13): HRFABMS (positive; NBA) m/z
1051.5673 (C52H84O16N4P,  5.3 mmu); 1H NMR (MeOH-d4 at 300 K)solution was basified by the addition of three drops of triethylamine
and evaporated. The product was purified by ODS HPLC with 55%  0.83 (3H, d, H46), 0.93 (3H, s, H43), 0.98 (3H, d, H42), 1.04 (3H, d,
H47), 1.23 (3H, s, H44), 1.30 (3H, d, H41), 1.50 (1H, m, H14a), 1.57MeCN containing 50 mM AcONH4 to furnish calyculin A bisaceto-
nide. The bisacetonide was dissolved in 80% AcOH (500 l) and (1H, m, H12), 1.69 (1H, m, H22), 1.72 (1H, m, H20a), 1.80 (1H, m,
H31a), 1.82 (1H, m, H20b), 1.86 (1H, m, H14b), 1.86 (3H, s, H48), 2.01stirred at 50C overnight. The reaction mixture was purified by ODS
HPLC with 48% MeCN containing 50 mM AcONH4 to afford 34,35- (1H, m, H31b), 2.03 (3H, s, H49), 2.03 (3H, s, Ac), 2.08 (1H, m, H24a),
2.09 (3H, s, H50), 2.43 (1H, m, H24b), 2.81 (1H, m, H10), 2.86 (6H, s,O-isopropylidene-calyculin A (11, 1.2 mg).
34,35-O-isopropylidene-calyculin A (11) : HRFABMS (positive; H39,40) 3.06 (1H, m, H32a), 3.20 (1H, m, H32b), 3.42 (3H, s, H38),
3.51 (1H, dd, H11), 3.55 (1H, m, H13), 3.60 (3H, s, H45), 3.79 (1H, m,NBA) m/z 1049.5842 (C53H86O15N4P,  1.5 mmu); 1H NMR (MeOH-
d4 at 300 K)  0.76 (3H, d, H46), 0.90 (3H, s, H42), 0.98 (3H, s, H43), H15), 3.80 (1H, m, H35), 3.83 (1H, m, H32), 3.94 (1H, m, H36), 4.00
(1H, dd, H16), 4.24 (1H, dd, H17), 4.39 (1H, m, H23), 4.39 (1H, m,1.06 (3H, d, H47), 1.24 (3H, s, H44), 1.44 (3H, d, H41), 1.36 (3H, s,
acetonide-Me), 1.53 (3H, s, acetonide-Me), 1.53 (1H, m H14a), 1.60 H34), 4.84 (1H, m, H21), 5.27 (1H, s, H2), 6.13 (1H, d, H9), 6.22 (1H,
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d, H26), 6.18 (1H, d, H4), 6.77 (1H, d, H6), 6.88 (1H, ddt, H25), 7.15 Received: August 9, 2001
Revised: November 22, 2001(1H, dd, H5), 7.67 (1H, s, H25).; 13C NMR (MeOH-d4 at 300 K)  10.8
(C42), 12.2 (C46), 14.5 (C48), 14.8 (C49), 18.0 (C41), 18.1 (C44), 18.5 Accepted: November 27, 2001
(C47), 18.7 (C50), 23.5 (C43), 38.5 (C20), 30.5 (C30), 35.0 (C31), 36.0
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Note Added in Proof
A crystal structure of a complex between calyculin A and PP1 was
recently determined (Kita, A., Matsunaga, S., Takai, A., Kataiwa, H.,
Wakimoto, T., Fusetani, N., Isobe, M., and Miki, K. (2002). Crystal
structure of the complex between calyculin A and the catalytic sub-
unit of protein phosphatase 1. Structure, in press).
